Caring Mill Cough Drops Cherry

Description

CoughDrops-421 is a pharmaceutical formulation designed for the relief of cough symptoms. The product is presented in a lozenge dosage form, facilitating ease of administration. CoughDrops-421 is characterized by its specific active ingredients, which are formulated to provide effective symptomatic relief. The lozenges are designed to dissolve slowly in the mouth, allowing for prolonged contact with the mucosal surfaces of the throat. The appearance of CoughDrops-421 is consistent with standard lozenge formulations, ensuring patient acceptance and compliance.

Uses and Indications

This drug is indicated for the temporary relief of cough due to a cold and for the alleviation of occasional minor irritation, pain, sore mouth, and sore throat.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 2 years and older should dissolve one lozenge slowly in the mouth. This process may be repeated every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is recommended to consult a doctor before administration.

Contraindications

Use of this product is contraindicated in situations where it may be accessible to children, as there is a risk of accidental ingestion. It is essential to ensure that this and all medications are stored securely out of the reach of children to prevent potential harm. No other specific contraindications have been identified.

Warnings and Precautions

Severe sore throat symptoms warrant immediate medical attention. If a sore throat is severe, persists for more than two days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

Prior to using this product, patients should seek medical advice if they have a persistent or chronic cough, particularly if it is associated with smoking, asthma, or emphysema. Additionally, individuals experiencing a cough accompanied by excessive phlegm (mucus) should also consult a healthcare provider.

During the use of this product, it is crucial not to exceed the recommended dosage.

Patients should discontinue use and consult a doctor if any of the following occur: a cough persists for more than one week, tends to recur, or is accompanied by fever, rash, or a persistent headache, as these may indicate a serious underlying condition. Furthermore, if symptoms of a sore mouth do not improve within seven days, or if irritation, pain, or redness persists or worsens, medical advice should be sought.

Side Effects

Patients may experience a range of adverse reactions while using this product. Serious adverse reactions include severe sore throat, which, if it persists for more than 2 days or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, necessitates prompt consultation with a healthcare professional. Additionally, patients are advised to seek medical advice before using this product if they have a persistent or chronic cough, such as that associated with smoking, asthma, or emphysema, or if their cough is accompanied by excessive phlegm.

Common adverse reactions may include sore throat symptoms that do not improve within 7 days. Patients should discontinue use and consult a doctor if their cough persists for more than 1 week, tends to recur, or is accompanied by fever, rash, or persistent headache, as these may indicate a serious underlying condition. Furthermore, if symptoms of sore mouth, irritation, pain, or redness persist or worsen, medical advice should be sought.

It is crucial for patients to adhere to the recommended dosage and to be vigilant regarding the persistence of symptoms, as exceeding the recommended dosage may lead to additional complications.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Caring Mill Cough Drops Cherry (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before use. For children aged 2 years and older, the lozenge should be dissolved slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a physician.

There is a choking hazard associated with small parts for children under 4 years of age. It is recommended that children be seated and supervised while consuming the lozenge to mitigate this risk.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

There is no specific information available regarding the use of this medication during pregnancy, including safety concerns, dosage modifications, or special precautions that should be taken. Healthcare professionals are advised to consider the lack of data when prescribing this medication to pregnant patients. The potential risks and benefits should be carefully evaluated, and alternative treatments may be considered in consultation with the patient. Women of childbearing potential should be informed of the absence of established safety data during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of this medication in nursing mothers. Additionally, there are no specific warnings or recommendations related to lactation. Healthcare professionals should consider the absence of data when advising lactating mothers on the use of this medication.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

Exceeding the recommended dosage of this product may lead to serious health consequences. Healthcare professionals are advised to monitor patients closely for any signs of overdosage and to take appropriate action if such symptoms arise.

Recommended Actions

In the event of suspected overdosage, immediate medical attention should be sought. It is crucial to assess the patient's condition and provide supportive care as necessary.

Potential Symptoms

Symptoms of overdosage may vary depending on the specific circumstances and individual patient factors. Healthcare providers should be vigilant for any unusual or severe reactions that may indicate an overdose.

Management Procedures

Management of overdosage should be tailored to the individual patient and may include symptomatic treatment and supportive measures. Continuous monitoring of vital signs and laboratory parameters is recommended to ensure patient safety and to guide further therapeutic interventions.

In all cases, adherence to the recommended dosage guidelines is essential to minimize the risk of overdosage and its associated complications.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication and all other drugs out of the reach of children. It is essential to emphasize the importance of proper storage to prevent accidental ingestion or misuse. Patients should be informed about the potential risks associated with leaving medications accessible to children and encouraged to take necessary precautions to ensure safety in their home environment.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is kept away from excessive heat and direct sunlight to maintain its integrity.

Healthcare professionals should also be vigilant in inspecting the primary bag seal; the product should not be used if the seal has been torn or broken, as this may compromise the safety and efficacy of the product. Proper handling and storage conditions are crucial for preserving the quality of the product throughout its shelf life.

Additional Clinical Information

For patients aged 2 years and older, the recommended administration involves dissolving the lozenge slowly in the mouth, with the option to repeat every 2 hours as needed or as directed by a healthcare professional. For children under 2 years of age, it is advised to consult a doctor before use.

Drug Information (PDF)

This file contains official product information for Caring Mill Cough Drops Cherry, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)